Brigimadlin

• Description :

  Brigimadlin (BI 907828) is an orally active and highly potent E3 ubiquitin-protein ligase MDM2-p53 antagonist with antitumor activity.Brigimadlin can be used to study metastatic BTC, PDAC, lung adenocarcinoma, or bladder cancer.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  591.46

• Molecular Formula :

  C31H25Cl2FN4O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Mdm2 | p53

• CAS Number :

  2095116-40-6